MFLRC - MF License & Regulatory Consultants

August 11, 2026 · Medical Device

Medical Device Recalls in Canada: What Counts, What You Must Report, and the 24-Hour Clock

By Mussarat Fatima

Medical DeviceComplianceQuality AssuranceRegulatory Affairs
Medical Device Recalls in Canada: What Counts, What You Must Report, and the 24-Hour Clock

A recall is one of the few regulatory events that can move from a quiet internal decision to a public Health Canada listing in a single day. For medical device manufacturers, importers and distributors, the rules that govern that moment sit in the Medical Devices Regulations (SOR/98-282) and in Health Canada's guide for recalling medical devices, GUI-0054. They are more demanding, and more surprising, than most teams expect. This guide explains what actually counts as a recall in Canada, what you are legally required to report, and the 24-hour clock that starts the moment you decide to act.

Executive summary

In Canada, a recall is not defined by whether product physically comes back. A corrective action taken because a device may be unsafe or may not meet its specifications is a recall, even when the device stays in use in the field. Health Canada recently listed a Type II recall with the plain statement that the product did not need to be removed or returned and could continue to be used as intended. If your team assumes that nothing coming back means nothing to report, that assumption is wrong and it is the single most common way device firms fall out of compliance.

Three obligations sit at the centre of the regime. You must notify Health Canada within 24 hours of deciding to recall a reportable device. You must file an initial recall report on or before you begin the recall. You must file a final recall report within 30 calendar days of completing it. Miss any of these and the recall itself becomes an inspection finding. With the MDEL Phase II amendments coming into force on 14 December 2026, establishment licence holders are already under scrutiny, so a defensible recall procedure has never mattered more.

What counts as a recall in Canada

What it is: under Canadian law a recall is any action taken to deal with a device that may be unsafe, defective, or not compliant with the Regulations. Why it matters: the definition turns on the defect and the corrective action, not on the logistics of return. What to do: treat any field safety corrective action, correction, or notice sent because of a potential defect as a recall candidate and run it through your recall decision process.

This is where many quality teams go wrong. A field safety notice, a software patch, a labelling correction, or an instruction to inspect a device before further use can all be recalls in the Canadian sense. The word people fixate on is return. The word the Regulations care about is correction. A recall can be a correction made to a device where it sits, and it is still posted, classified, and given an RA number like any other.

A recent Canadian example makes the point cleanly. Health Canada listed a Type II recall of an ophthalmic viscoelastic device and stated that the recall did not require removal or return of the product from the market, and that the product could continue to be used as intended. It was still a recall. It was still classified, numbered, and published. If you had waited for product to come back before reporting, you would already have been late.

The three recall classifications, with 2026 Canadian examples

What it is: Health Canada classifies recalls as Type I, II, or III based on the probability and severity of harm. Why it matters: the classification drives your reporting urgency, your effectiveness checks, and how closely Health Canada watches. What to do: assign a risk level to every recall using a documented risk evaluation, and remember that a Type III can still be reportable if the device could cause serious injury.

Recall typeWhat it meansReportable to Health Canada?
Type IA reasonable probability that use of the device will cause serious adverse health consequences or death.Yes. Report and treat as highest urgency.
Type IIUse may cause temporary or medically reversible adverse health consequences, or the probability of serious consequences is remote.Yes.
Type IIIUse is not likely to cause an adverse health consequence.Not automatically. Still reportable under section 63.1 if the device could cause serious injury to health.

Three date-verified Canadian device recalls from early August 2026 each dismantle a common client assumption.

DeviceClassificationThe lesson
Bravo capsule delivery system (Medtronic / Given Imaging)Type IRoot cause partly attributed the failure to not following the user guide. The classification stayed Type I. Depending on the user to avoid harm is a design risk, not a defence.
Beckman Coulter AU480 analyzerType IIA Microsoft SQL Server 2022 Express connection defect prevented instrument startup. Off-the-shelf software configuration became a reportable recall.
HEALON EndoCoat PRO (J&J Surgical Vision)Type IIHealth Canada stated the recall did not require removal or return and the product could continue to be used as intended. A corrective communication is still a recall.

What triggers a reporting obligation

What it is: sections 63.2, 64 and 65 of SOR/98-282 apply when the device is likely to cause injury to health, or could cause serious injury to health. Why it matters: reportability is set by potential harm, not by recall type alone. What to do: run every recall through the section 63.1 reportability test before you decide it is a non-reportable correction.

Section 63.1 states that the reporting sections apply if the device is likely to cause injury to health, or could cause serious injury to health. Type I and Type II recalls are reportable. A Type III may also be reportable where the device could cause serious injury, regardless of how remote the probability is. Recalls of unlicensed devices are expected to be reported, because those devices were never reviewed for safety and effectiveness. When in doubt, Health Canada allows you to report as a precaution. The full text of section 64 of the Medical Devices Regulations sets out the initial report content in detail.

Note who is out of scope. Sections 63.2, 64 and 65 do not apply to a retailer, or to a health care facility where the device is distributed for use inside the facility. They fall squarely on manufacturers and importers. Distributors still have obligations under their own procedures and quality agreements, but the statutory recall reports rest with the manufacturer and the importer.

Reporting timelines and the FRM-0360 forms

What it is: the regime runs on three clocks, a 24-hour notification, an initial report on or before the recall starts, and a final report within 30 calendar days of completion. Why it matters: the deadlines are short and they begin at the decision, not at the shipment. What to do: build the timeline into your recall SOP with named owners and the correct Health Canada forms.

Under section 63.2, once you decide to recall a reportable device without being ordered to, you must give Health Canada an initial notification in writing within 24 hours of that decision. This is the 24-hour clock, and it starts at the internal decision point, before a single unit has moved. The notification includes the device name and identifier, the licence or authorization number, the names and addresses of the manufacturer, the fabrication site and the importer, the reason for the recall, and a preliminary risk evaluation.

Under section 64 you submit the initial recall report on or before the day you begin the recall, meaning the day you start sending recall notifications. Under section 65 you submit the final recall report within 30 calendar days after the recall is complete. Health Canada provides two forms for these reports.

TriggerWhat to submitDeadlineForm / section
Decision to recall a reportable deviceInitial notification with preliminary risk assessmentWithin 24 hours of the decisionSection 63.2
Start of the recall (first notifications sent)Initial recall report with full section 64 content and strategyOn or before you begin the recallFRM-0360A, section 64
Completion of the recallFinal recall report on results and preventive actionWithin 30 calendar days of completionFRM-0360B, section 65
Health Canada request during an open recallInterim or progress reportAt the agreed intervalsProgress report content

All reports go to the Medical Devices Compliance program by email. For a Type I recall, the contact person you name must be reachable on a 24-hour basis. Section 65.1 allows a manufacturer to permit the sole Canadian importer to prepare and submit identical reports on the manufacturer's behalf, but the manufacturer must tell Health Canada in writing that it has done so. Absent that designation, both the manufacturer and the importer file.

Software and off-the-shelf components are in scope

What it is: a defect in embedded or connected software, including commercial off-the-shelf software, can make a device fail and become a reportable recall. Why it matters: many teams treat third-party software as outside the device boundary. What to do: bring software of unknown provenance and off-the-shelf components inside your configuration control and validation programme.

The Beckman Coulter AU480 case is the teaching example. A connection defect involving Microsoft SQL Server 2022 Express, an off-the-shelf database engine, prevented the analyzer from starting and could delay patient results. That was enough for a Type II recall. The lesson is that once you build a commercial component into your device, its behaviour is your responsibility, and a change or defect in that component can trigger the same reporting duties as a hardware fault. Firms working with adaptive or connected software should also review our guidance on machine learning enabled medical devices and PCCP, where change control is central.

When user error is not a defence

The Bravo capsule case shows a trap in root cause analysis. The investigation partly attributed the failure to not following the user guide, yet the recall stayed Type I. Blaming user technique does not lower the classification when the harm is serious and the design depends on the user to avoid it. If a device can be used incorrectly in a way that causes serious harm, that is a design and human factors risk you must control, not a reason to downgrade. Weak or misdirected root cause is also why so many corrective actions fail, a theme we cover in why CAPA keeps failing.

Building a recall procedure that survives inspection

A recall procedure is only as good as the distribution records behind it. Section 52 of the Regulations requires distribution records that let you trace where affected units went. If you cannot produce a complete consignee list quickly, you cannot run an effective recall, and Health Canada will see that gap. The best way to prove your procedure works is to test it before you need it. A documented mock recall measures the time from first signal to a complete lot list, the percentage of direct consignees reached within 24 hours, and whether your identifiers survive at each step of the supply chain.

Timing matters. The MDEL Phase II amendments come into force on 14 December 2026, tightening establishment licence obligations for importers and distributors. Recall readiness is a natural part of that preparation, because a licence holder is expected to have working recall and complaint procedures, not just a written SOP on a shelf.

Medical device recall compliance checklist

  • A written recall SOP that defines a recall to include corrections and field actions, not only physical returns.
  • A documented reportability assessment against section 63.1 for every recall decision.
  • A pre-drafted section 63.2 notification template that can be issued within 24 hours of the decision.
  • Named owners for the initial report (FRM-0360A) and the final report (FRM-0360B), with backup contacts.
  • Distribution records under section 52 that produce a complete consignee list on demand.
  • A risk evaluation method that assigns Type I, II or III consistently and captures the rationale.
  • A 24-hour reachable contact for Type I recalls, named in the procedure.
  • Configuration control that includes off-the-shelf software and components used in the device.
  • Effectiveness checks and a final report filed within 30 calendar days of completion.
  • A mock recall run at least annually, with measured key performance indicators.

Common mistakes

  • Treating no product return as no recall. A correction in the field is still a recall and still reportable.
  • Starting the 24-hour clock at shipment. The clock starts at the decision to recall, under section 63.2.
  • Excluding third-party software. Off-the-shelf components inside your device are within scope.
  • Using user error to downgrade classification. If the design lets serious harm happen, the recall type holds.
  • Assuming Type III is never reportable. Section 63.1 can make it reportable where serious injury is possible.
  • Forgetting the final report. Section 65 requires it within 30 calendar days of completion, with results and preventive action.

Frequently asked questions

Is a field safety notice a recall in Canada?

Usually yes. A field safety corrective action taken because a device may be unsafe or may not meet its specifications meets the Canadian meaning of a recall, even if the notice only asks users to inspect, adjust, or update the device where it sits. Run it through your reportability assessment rather than assuming a notice is exempt.

Do I have to report a recall if no product is returned?

Yes, when the device is likely to cause injury to health or could cause serious injury. Reportability under section 63.1 depends on potential harm, not on whether product physically returns. Health Canada has listed reportable recalls where the product stayed in use and did not need to be returned.

How long do I have to report a medical device recall in Canada?

You must notify Health Canada within 24 hours of deciding to recall, under section 63.2. You file the initial recall report on or before you begin the recall, under section 64, and the final recall report within 30 calendar days of completion, under section 65.

What is the difference between a Type I, II and III recall?

Type I means a reasonable probability of serious harm or death. Type II means temporary or reversible harm, or a remote probability of serious harm. Type III means harm is not likely. Type I and II are reportable, and a Type III can still be reportable where the device could cause serious injury.

Which form do I use, FRM-0360A or FRM-0360B?

Use FRM-0360A for the initial recall report under section 64, filed on or before you begin the recall. Use FRM-0360B for the final recall report under section 65, filed within 30 calendar days of completion. Both are optional templates, but they map to the exact content the Regulations require.

Does user error excuse a device recall?

No. If a device can be misused in a way that causes serious harm, that is a design and human factors risk. Attributing a failure to not following the instructions for use does not lower the recall classification, as the Bravo Type I case shows.

How MFLRC can help

MFLRC helps medical device manufacturers, importers and distributors build recall programmes that hold up under a Health Canada review. Our senior consultants design recall SOPs and decision trees, draft section 63.2 notification and FRM-0360 templates, and run measured mock recalls that expose gaps before an inspector does. We support MDEL applications and Phase II readiness, computerised system validation for software-dependent devices, CAPA and root cause programmes, and full gap assessments across your quality system. Explore our audit services and our medical devices practice to see how we work.

Would your recall procedure survive a Health Canada review? Book a consultation for a recall-readiness gap assessment and we will tell you where you stand.

Conclusion

In Canada, a recall is defined by the correction, not the return. The obligations are precise, the deadlines are short, and the 24-hour clock starts the instant you decide to act. Firms that write their procedures around the harm and the timeline, keep clean distribution records, and test the whole thing with a mock recall are the ones that come through an inspection intact. With MDEL Phase II arriving on 14 December 2026, now is the moment to make sure your recall programme is more than paper.

Sources and references

Downloadable Resource

Medical Device Recall Readiness Checklist

A one-page, print-ready checklist covering the 24-hour notification, FRM-0360 initial and final reports, reporting timelines, and the records a Health Canada reviewer will expect. Built from the compliance checklist in this article.

File: MFLRC-Medical-Device-Recall-Readiness-Checklist.pdf

Fill in your details below and the download link will appear right away.

Share with others

Tags

Medical DevicesRecall ReadinessHealth CanadaMDELInspection ReadinessCompliance
Book a consultation